Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase 2 1

Status

Terminated 3Completed 2

Sponsor Class

INDUSTRY 5OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 4Tumor-Agnostic 1

Conditions

Head and Neck Neoplasms 6Neoplasms 5Carcinoma, Squamous Cell 4Sarcoma, Kaposi 3Hodgkin Disease 3HIV Infections 3Acquired Immunodeficiency Syndrome 3Squamous Cell Carcinoma of Head and Neck 2Lymphoma 2Carcinoma 2Skin Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Laryngeal Diseases 1Hematologic Diseases 1Breast Neoplasms 1

Interventions

pembrolizumab 133Gemcitabine 101Paclitaxel 100Carboplatin 84Nivolumab 66Docetaxel 62Bevacizumab 62Cisplatin 57Pemetrexed 50Fluorouracil 49Cyclophosphamide 41Cetuximab 41trametinib 38venetoclax 37Leucovorin 37Irinotecan 37Sorafenib 35Capecitabine 35Ipilimumab 33Dexamethasone 32atezolizumab 31Erlotinib Hydrochloride 28130-nm albumin-bound paclitaxel 28Drug Therapy 27Epoetin Alfa 26Doxorubicin 25Oxaliplatin 24Albumin-Bound Paclitaxel 24Prednisone 23Rituximab 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms × Bleomycin × Clear all
NCT00198315 2022-03-04

Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

Inovio Pharmaceuticals

Phase 3 Terminated
130 enrolled
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

NCT00198328 2022-03-04

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

Inovio Pharmaceuticals

Phase 3 Terminated
84 enrolled
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

NCT01606566 2022-02-18

A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

PCI Biotech AS

Phase 2 Terminated
26 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Recurrence

NCT00198263 2017-10-03

Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

Inovio Pharmaceuticals

Phase 4 Completed
95 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms

NCT00198276 2017-10-03

Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer

Inovio Pharmaceuticals

Phase 4 Completed
88 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡